Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
All clinical confidence ratings above apply to human outcomes, not animal findings
Advancing real time visibility
Who IGF-1 LR3 Is For and Who Should Avoid It IGF-1 LR3 has no FDA-approved human indication
The proposed mechanism is indirect modulation of the NO pathway rather than direct receptor agonism, though the precise molecular binding event has not been definitively characterized in peer-reviewed work
Lets break it down
In this study, both AOD9604 and HA individually led to improved cartilage outcomes and shorter periods of lameness compared to saline control
US$ 20.47
US$ 28.56
US$ 26.17
